Applied Nutrition has reported a 44% rise in pre-tax profit to £40.6m for the year ending July, as the sports supplement maker capitalises on demand for weight-loss jabs and GLP-1-friendly products.
Revenue surged 50% to £161.6m, driven by the company's launch of protein shakes and supplements designed for consumers using weight-loss medication. The offerings include creatine and liquid collagen pouches, alongside "digest capsules" containing enzymes, probiotics and fibre to "promote digestive comfort" and "gut health".
Market Trends and GLP-1 Growth
The company told shareholders that "the global sports nutrition, health and wellness market continues to grow rapidly as consumers are becoming more health conscious." It cited research from the Institute of Grocery Distribution showing the proportion of British consumers using weight-loss medication jumped from 3.1% last June to 6% this March.
"These shifting trends are creating opportunities across both established and emerging categories," the firm said. Its new GLP-1-friendly ranges have "helped us remain at the forefront of the market while retaining the agility to adapt as demand changes," it added.
Product Expansion and Partnerships
Alongside the rising popularity of weight-loss drugs, female gym-goers are increasingly driving demand for products such as collagen and creatine, Applied Nutrition said. The Merseyside-based company has also forged partnerships with brands including Slush Puppie, Sour Patch Kids and Swedish Fish to maintain relevance among younger consumers.
Thomas Ryder, the former scaffolder who established the company in 2014, said the group is heading into its new financial year with "very strong momentum". He added: "Consumer demand for health, wellness and performance nutrition continues to grow and the market is moving quickly. We stay close to our customers, listen to what consumers want and move fast when we see an opportunity."
Investor Support and Market Performance
Since its inception just over a decade ago, Applied Nutrition has been bolstered by high-profile investors, including Coleen Rooney, former JD Sports chief executive Peter Cowgill and petrol forecourt tycoon Mohsin Issa. Milo Bussell, an analyst at stockbroker Cavendish, said the protein shake maker is "going from strength to strength".
The firm's market backdrop is "highly supportive with consumers prioritising health and wellness and retailers expanding shelf space for the category," he said. Shares in Applied Nutrition have climbed 133% since its IPO in October 2024, with the group up 23% in the year to date.